CollPlant Biotechnologies (CLGN) Shares Outstanding (Weighted Average) (2018 - 2025)

CollPlant Biotechnologies' Shares Outstanding (Weighted Average) history spans 8 years, with the latest figure at $12.2 million for Q4 2025.

  • For Q4 2025, Shares Outstanding (Weighted Average) rose 6.54% year-over-year to $12.2 million; the TTM value through Dec 2025 reached $12.2 million, up 6.54%, while the annual FY2025 figure was $12.2 million, 6.54% up from the prior year.
  • Shares Outstanding (Weighted Average) reached $12.2 million in Q4 2025 per CLGN's latest filing, up from $11.5 million in the prior quarter.
  • In the past five years, Shares Outstanding (Weighted Average) ranged from a high of $12.2 million in Q4 2025 to a low of $186000.0 in Q4 2023.
  • Average Shares Outstanding (Weighted Average) over 5 years is $9.0 million, with a median of $11.0 million recorded in 2022.
  • Peak YoY movement for Shares Outstanding (Weighted Average): plummeted 98.31% in 2023, then skyrocketed 6058.16% in 2024.
  • A 5-year view of Shares Outstanding (Weighted Average) shows it stood at $10.0 million in 2021, then grew by 10.68% to $11.0 million in 2022, then tumbled by 98.31% to $186000.0 in 2023, then surged by 6058.16% to $11.5 million in 2024, then rose by 6.54% to $12.2 million in 2025.
  • Per Business Quant, the three most recent readings for CLGN's Shares Outstanding (Weighted Average) are $12.2 million (Q4 2025), $11.5 million (Q4 2024), and $186000.0 (Q4 2023).